International law firm Taylor Wessing has advised The Rohatyn Group on its investment in Optimapharm d.d. (Optimapharm), a contract research organisation headquartered in Croatia, with 14 offices across Europe, including a heavy presence in CEE. The investment establishes a partnership with the company’s founders Gordana Gregurić Čičak and Igor Čičak.
Optimapharm organises and manages clinical trials for US and Western European pharmaceutical companies, biotech players and medical device companies. With the investment, Optimapharm will seek to continue to grow both organically and through strategic acquisitions.
The multijurisdictional deal required input from a number of foreign counsels focusing predominantly on Austria, Croatia, Czech Republic, Serbia and Switzerland.
The deal required expertise drawn from across the firm's private equity, banking and finance and tax teams.
Taylor Wessing is a full-service international law firm, working with clients in the world’s most dynamic industries. We take a single-minded approach to advising our clients, helping them succeed by thinking innovatively about their business issues. We support clients wherever they want to do business. The firm has a sector focus with experts in technology, media and communications, life sciences and private
